Open House Original Rebate Contracts 2026-05 Alectinib
Original notice title
Germany – Pharmaceutical products – Open-House-Originale-Rabattverträge 2026-05 Alectinib
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
30 / 100
Risk factors
The procedure is explicitly not a public procurement under EU directives; legal recourse is via social courts, not proc...
No estimated contract value or framework maximum is provided. Without this, it is impossible to assess the financial at...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Strong opportunityKey Facts
- Supplies contract
- 1 lot
- Duration until Jul 2028
- Conclusion of pharmaceutical rebate contracts (Rabattverträge) for the active substance Alectinib
- Non-exclusive, open to all eligible pharmaceutical entrepreneurs
Show full summary
This is an Open-House procedure (not a traditional public procurement) by Techniker Krankenkasse and other German health insurers for rebate contracts (Rabattverträge) under § 130c SGB V for the active substance Alectinib. Any eligible pharmaceutical entrepreneur can join at any time during the contract period (max 24 months starting 01.08.2026, ending 31.07.2028). No estimated value is provided. The procedure is non-exclusive with uniform conditions. Submission is via email or postal mail at any time. The tender documents are available online but were not analyzed. Notably, the procedure is not subject to standard procurement law; disputes go to social courts.
Risks
The procedure is explicitly not a public procurement under EU directives; legal recourse is via social courts, not proc...
No estimated contract value or framework maximum is provided. Without this, it is impossible to assess the financial at...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Must be a pharmaceutical entrepreneur (pharmazeutischer Unternehmer) as defined in §4 Abs.18 AMG
- Must hold a valid marketing authorization for the medicinal product containing Alectinib
- Must have seat in Germany, EU, or EEA
Requirements may be incomplete.
Buyer
Location
Hamburg, DEU
Website
Identifier
992-80116-93
Activity
Health
Lots (1)
LOT-0001
Open House Original Rebate Contracts 2026-05 Alectinib
Conclusion of pharmaceutical rebate contracts for the active substance Alectinib under an Open-House procedure. The contract duration is up to 24 months, starting 01.08.2026, with automatic termination upon patent expiry. Participation is possible throughout the contract period.
Location
Duration
Category
Deadline
Award details
Ziel ist der Abschluss von Arzneimittelrabattverträgen nach § 130c Abs. 1 SGB V zu dem Wirkstoff Alectinib im Rahmen eines Open-House-Verfahrens.
Value note
Show original TED data
Original lot title
Open-House-Originale-Rabattverträge 2026-05 Alectinib
Original TED description
Ziel ist der Abschluss von Arzneimittelrabattverträgen nach § 130c Abs. 1 SGB V zu dem Wirkstoff Alectinib im Rahmen eines Open-House-Verfahrens.
Procurement Details
- Publication date
- 01 Jul 2026
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 455118-2026
Documents (1)
Similar tenders
Germany – Site preparation work – VE111 Baustelleneinrichtung (119VM514 / Kronsh,SanDstBw,Ersatzneub. ZInstSanBw)
Poland – Advertising and marketing services – Zaplanowanie i realizacja kampanii Ministerstwa Finansów z zakresu działalności resortu finansów
France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord
Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)
Greece – Cultural event organisation services – ΛΕΙΤΟΥΡΓΙΑ ΤΟΥ ΘΕΑΤΡΟΥ ΟΛΥΜΠΙΑ ΜΑΡΙΑ ΚΑΛΛΑΣ ΜΕ ΕΞΕΙΔΙΚΕΥΜΕΝΟ ΠΡΟΣΩΠΙΚΟ
Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
30 / 100
Risk factors
The procedure is explicitly not a public procurement under EU directives; legal recourse is via social courts, not proc...
No estimated contract value or framework maximum is provided. Without this, it is impossible to assess the financial at...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications